ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 224 out of 3734

$816K Total Retail Price of All Prescriptions

Rank: 201 out of 3734

404 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 10,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 603 509 1 1
FUROSEMIDE 547 469 2 7
LISINOPRIL 546 467 3 3
OMEPRAZOLE 416 313 4 4
LEVOTHYROXINE SODIUM 337 276 5 2
CARVEDILOL 322 252 6 30
METFORMIN HCL 292 221 7 8
AMLODIPINE BESYLATE 287 231 8 5
METOPROLOL SUCCINATE 272 241 9 14
ATORVASTATIN CALCIUM 270 198 10 11
POTASSIUM CHLORIDE 231 192 11 19
DIGOXIN 224 199 12 43
ZOLPIDEM TARTRATE 221 176 13 24
HYDROCODONE-ACETAMINOPHEN 221 145 S3 13 12
LOSARTAN POTASSIUM 208 181 15 21
GLIMEPIRIDE 198 174 16 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 164 17 27
METOPROLOL TARTRATE 195 188 17 6
AMLODIPINE BESYLATE-BENAZEPRIL 181 157 19 56
ZETIA 173 129 20 55
DIOVAN 167 144 21 31
PANTOPRAZOLE SODIUM 165 123 22 22
WARFARIN SODIUM 157 145 23 10
ATENOLOL 155 117 24 13
CITALOPRAM HBR 151 135 25 16
GABAPENTIN 149 60 26 17
HYDROCHLOROTHIAZIDE 148 118 27 9
KLOR-CON M20 145 115 28 48
CRESTOR 145 109 28 28
CLOPIDOGREL 143 106 30 23
SERTRALINE HCL 141 136 31 18
CYMBALTA 126 73 32 67
NEXIUM 125 89 33 36
PREDNISONE 102 96 34 42
TRAMADOL HCL 92 53 35 20
PLAVIX 91 69 36 39
RAMIPRIL 85 80 37 91
EXFORGE 85 37 37 183
VENLAFAXINE HCL ER 83 44 39 84
AZITHROMYCIN 82 62 40 38
PRAVASTATIN SODIUM 82 82 40 15
TAMSULOSIN HCL 76 64 42 29
DILTIAZEM 24HR ER 75 75 43 86
OXYCODONE-ACETAMINOPHEN 74 72 S2 44 51
DONEPEZIL HCL 73 65 45 25
PREMARIN 68 31 R 46 246
ISOSORBIDE MONONITRATE ER 67 50 47 34
ALENDRONATE SODIUM 67 67 47 26
SPIRIVA 66 37 49 40
LANSOPRAZOLE 65 55 50 155
NAMENDA 62 54 51 44
GLIPIZIDE XL 62 60 51 85
ADVAIR DISKUS 59 47 53 35
FENTANYL 56 48 S2 54 65
RANITIDINE HCL 56 43 54 32
AMITRIPTYLINE HCL 56 30 R 54 94
LOVASTATIN 55 44 57 41
LANTUS SOLOSTAR 54 31 58 102
TRICOR 53 43 59 93
DIOVAN HCT 52 22 60 72
OXYCONTIN 50 34 S2 61 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.